LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Home・Список акций・ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc

Закрыт

СекторЗдравоохранение

21.33 0.23

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

20.82

Макс.

21.64

Ключевые показатели
By Trading Economics
Доход	-270M 3.6M
Продажи	-16M 268M
P/E Средняя по отрасли	9.819 49.052
Прибыль на акцию	0.02
Рентабельность продаж	1.357
Сотрудники	796
EBITDA	-31M -4.6M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+51.44% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 авг. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-83M 3.7B
Предыдущая цена открытия	21.1
Предыдущая цена закрытия	21.33

Новостные настроения

By Acuity

28%

72%

154 / 344 Рейтинг в Healthcare

ACADIA Pharmaceuticals Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 июн. 2026 г., 23:56 UTC

News

Monster Beverage shares higher in after-market trading following Bernstein's initiation of coverage with a Market Perform rating. The stock has gained over four consecutive sessions.

11 июн. 2026 г., 23:52 UTC

Macro Event

News

Correlated Moves

The Australian Dollar has gained against the Singapore Dollar, supported by a slight decline in consumer inflation expectations and recent geopolitical developments.

11 июн. 2026 г., 23:51 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting concerns over inflation following a rise in the producer price index.

11 июн. 2026 г., 23:51 UTC

Correlated Moves

ETF Constituents

News

Social Media

SPDR S&P 500 ETF Trust rises in after-hours trading amid improved market sentiment and reduced geopolitical tensions in Iran, supported by strong performances from top holdings.

11 июн. 2026 г., 23:51 UTC

Correlated Moves

ETF Constituents

News

Social Media

Invesco QQQ Trust Series I rises after hours, supported by a Nasdaq 100 rally driven by technology stocks and easing inflation concerns.

11 июн. 2026 г., 23:51 UTC

News

The United States Oil Fund LP is higher in after-market trading amid reports of explosions in Iran raising concerns over oil supply stability.

11 июн. 2026 г., 23:41 UTC

Social Media

News

Event

Adobe Inc. shares fell in after-market trading despite record revenue of $6.62 billion, as investor concerns grew over CFO Dan Durn's upcoming departure.

11 июн. 2026 г., 23:41 UTC

ETF Constituents

Correlated Moves

Macro News

News

Vanguard Information Technology ETF rises after President Trump's decision to call off attacks against Iran, boosting investor confidence and contributing to gains in major indices.

11 июн. 2026 г., 23:41 UTC

Social Media

News

Western Digital Corp initiated exchange agreements with investors for over 1 million shares of SanDisk, contributing to the stock's higher after-market hours movement.

11 июн. 2026 г., 23:36 UTC

News

Correlated Moves

Ethereum is trading higher as market optimism rises amid U.S.-Iran tensions and the European Central Bank's interest rate hike. Earlier, it pulled back from a peak.

11 июн. 2026 г., 23:31 UTC

News

NVIDIA shares are higher in after-market trading following an upgrade to 'AA' by S&P Global and the announcement of its 2026 Annual Meeting.

11 июн. 2026 г., 23:26 UTC

ETF Constituents

Correlated Moves

News

Vanguard Growth ETF rises in after-market trading, buoyed by gains from Microsoft, NVIDIA, and Alphabet, despite remaining below its 20-day moving average.

11 июн. 2026 г., 23:16 UTC

ETF Constituents

Social Media

News

Correlated Moves

The iShares Russell 2000 ETF rose in after-market hours, supported by the Russell 2000 index's significant gain and contributions from PR and SATS.

11 июн. 2026 г., 23:11 UTC

News

Correlated Moves

CME Group plans to expand 24/7 gold trading, pending regulatory review. SPDR Gold Shares are rising in after-market hours amid geopolitical tensions.

11 июн. 2026 г., 23:11 UTC

News

USD/PLN trades lower as natural gas storage exceeds forecasts and initial jobless claims rise unexpectedly. Volatility persists during Thursday's session.

11 июн. 2026 г., 23:11 UTC

News

Correlated Moves

The USD/CZK is trading lower, reflecting a decline since Wednesday's close amid rising initial jobless claims and producer prices exceeding forecasts.

11 июн. 2026 г., 23:06 UTC

Correlated Moves

News

Vanguard Total Bond Market ETF trades higher in after-market hours as producer prices exceed expectations, prompting bargain hunting despite potential interest rate hike concerns.

11 июн. 2026 г., 23:06 UTC

News

Amgen engages Duke Clinical Research Institute to reassess Tavneos data amid FDA concerns, with shares trading higher in after-market hours.

11 июн. 2026 г., 23:03 UTC

Social Media

Correlated Moves

News

iShares Silver Trust trades higher after geopolitical tensions in Iran raise interest in safe-haven assets, supported by gold's recent gains.

11 июн. 2026 г., 23:03 UTC

ETF Constituents

News

The Vanguard Small-Cap ETF is higher in after-market trading, reflecting a broader upward trend in the Russell 2000 Index amid ongoing inflationary concerns.

11 июн. 2026 г., 23:02 UTC

News

The USD/THB is lower as U.S. economic data raises inflation concerns, impacting sentiment and Federal Reserve policy expectations during Thursday's trading session.

11 июн. 2026 г., 23:02 UTC

News

Gilead Sciences reported positive results from two Phase 3 trials for an HIV treatment. Shares are higher in after-market hours following a session pullback.

11 июн. 2026 г., 23:02 UTC

News

The USD/HUF is trading lower, reflecting a drop since Wednesday. Rising jobless claims and surging producer prices raise concerns about labor market strength and inflation.

11 июн. 2026 г., 23:02 UTC

Correlated Moves

News

The USD/SEK is declining, breaking a trend of higher daily closes, amid rising initial jobless claims that may impact Federal Reserve policy.

11 июн. 2026 г., 22:51 UTC

Correlated Moves

News

USD/SGD declines amid natural gas storage data surpassing forecasts. The pair has experienced unusual volatility, peaking briefly before steady declines into the afternoon.

11 июн. 2026 г., 22:51 UTC

Correlated Moves

News

The CHF/HKD is higher during Thursday's session, supported by the European Central Bank's recent interest rate hike amid inflation pressures.

11 июн. 2026 г., 20:07 UTC

News

Correlated Moves

The European Central Bank raised interest rates by 25 basis points, supporting modest gains in GBP/HKD amid inflation pressures from the Middle East conflict.

11 июн. 2026 г., 20:07 UTC

News

Correlated Moves

Natural gas storage data showed 108 billion cubic feet, surpassing forecasts. USD/NOK is trading higher, remaining above its 20-day moving average.

11 июн. 2026 г., 20:07 UTC

News

Correlated Moves

The USD/DKK is lower in Thursday's session, reflecting a decline in the US Dollar Index amid rising initial jobless claims data.

11 июн. 2026 г., 20:06 UTC

News

Correlated Moves

Intel Corp's stock is rising following a double upgrade from Bank of America, which raised its price target to $135 from $96.

Сравнение c конкурентами

Изменение цены

ACADIA Pharmaceuticals Inc Прогноз

Целевая цена

By TipRanks

51.44% рост

Прогноз на 12 месяцев

Средняя 32.18 USD 51.44%

Максимум 38 USD

Минимум 23 USD

Основано на мнении 13 аналитиков Wall Street, спрогнозировавших целевые цены для ACADIA Pharmaceuticals Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

13 ratings

Покупка

Удержание

Продажа

Основано на мнении 13 аналитиков, присваивавших рейтинги акциям ACADIA Pharmaceuticals Inc – Данные за последние 3 месяца.

Настроения

By Acuity

154 / 344Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.